Joint workshop: Managed entry in the context of adaptive pathways (D3.05 & D3.07)

5th July 2016

London, United Kingdom

On the 5th of July 2016 ADAPT SMART organised a one day workshops entitled “Managed entry in the context of adaptive pathways.” The workshop was held in London and around 30 attendees represented key European stakeholder groups: health technology assessment (HTA) bodies, payer organisations, or manufacturers. The workshop was also attended by several patient representatives, healthcare professionals, and academics. The workshop was convened to discuss the findings of a series of interviews with HTA bodies, payers and industry representatives. The interviews discussed experiences with managed entry agreements for products that were introduced with considerable uncertainty at licensing in recent years (conditional approval/approval under exceptional circumstances).

The summary of the workshop can be found here.
A full report will follow later.

Separate report from Charles River Associates

As part of its work on ADAPT SMART, EFPIA commissioned CRA to conduct interviews on the experience with MEAs – Products with CMA or MA under exceptional circumstances were used as a proxy for MAPPs. The report and more information about it can be found here. The views expressed in this report are the views and opinions of the authors and do not necessarily reflect or represent the views of the ADAPT SMART consortium or its members.